Symposium Agenda

8:00 AMRegistration, Networking & BreakfastPicasso 1-6
9:00 AMOpening Remarks

Rachel Robinson
Chief Operating Officer, MassMEDIC

Adrienne Zepeda
Group Director, Informa Markets

Joe Shonkwiler, MD
Chief Operating Officer
Advanced Research Projects, Agency for Health (ARPA-H)
Picasso 1-6
9:15 AMAI in Medtech: The Technology of Intelligent Machines
The field of AI is rooted in the desire to make computer programs “intelligent” in the various ways that we regard human cognition as such. From this arises a collection of approaches drawing from many disciplines, and within each are numerous evolving techniques. Certain recent successes in the field, most notably GPTs, have generated (pun intended) tremendous media hype; but these are just one corner of a vast, rich, and diverse area of computer science and engineering. Join our panel of experts as they discuss which approaches to AI have been successful in medtech, what hasn’t worked, what techniques remain unexplored, and why.

Todd Usen, Moderator
CEO, Minerva Surgical

Tom Calef
CTO, Activ Surgical

Sandra Nagale, PhD
Director, Digital Health, Boston Scientific

Jeff Valk
CEO, Admetsys

Picasso 1-6
10:00 AMAI in Medtech: How We Did It
Contrary to some narratives, AI isn’t magic, and one size does not fit all. Successfully applying techniques in the field requires certain technical and organizational competencies. Applying these in medtech products is more challenging still, owing to the need for clinical safety and mitigation of regulatory risk. In this panel we’ll discuss how medtech companies build and organize multidisciplinary teams to develop and support AI systems for clinical use, architect for clinical safety in various types of AI systems, think about black box vs inspectable models in regulated environments, and manage regulatory pathways for learning systems.

Sanjeev Aggarwal, MD, MBA, Moderator
Vice President, Global Clinical and Medical Affairs for Surgical Therapies, Abiomed

Aseem Anand
Vice President, Head of Digital Biomarker Solutions, Lantheus

Liz Asai
Global Head of AI & Connectivity, Hologic

Alex Maret
Vice President, Robotics & Digital Surgery, Cambridge Consultants
Picasso 1-6
10:45 AMNetworking BreakPicasso 1-6
11:00 AMPersonalized Medicine: Expanding the Definition and Business Models
As the medical landscape evolves beyond the traditional one-size-fits-all approach, personalized medicine emerges as a transformative paradigm, offering treatments tailored to the unique genetic makeup and specific needs of individual patients. This shift is propelled by groundbreaking advancements in genomics, computational biology, regenerative medicine and AI in surgery and navigation, attracting significant investment from both the medical device and pharmaceutical sectors.

Deepak Sahu, Moderator
Managing Director, Trinity Lifesciences

Kimberly Gasuad
SVP Marketing & Business Development, IBEX

Carole K. Tremonti
CEO, Three Mountains

Arvind Ramadorai
Global Head of Innovation, Robotic Surgery Technologies, Medtronic

Kevin P. Smith
General Counsel & EVP, Business Development, SIRTeX
Picasso 1-6
11:45 PMLunch & NetworkingPicasso 7
1:00 PMBreakout Sessions
Cardiac Health Track
In our Cardiac Health Track, the conversation will center on the advancements in medical technology that improve cardiac care. From wearables to image-guided planning, implantable devices to AI driven diagnostics, medical technology collectively contributes to a more comprehensive and personalized approach to cardiac care, ultimately improving patient outcomes and quality of life.

The first session of the Cardiac Health Track will focus on measurement technologies and the use of data to track progression of cardiac conditions within individuals and populations. Next, we’ll dive into in-and out-patient cardiac interventions, including technology used in the Cath Lab such as ablation and implantable devices. Lastly, we’ll feature experts working in assistive technologies, used to monitor patients and help them to avoid re-hospitalization.
Monet 1-3
Diabetes Track
Our Diabetes Track will look at the evolution of diabetes care, particularly how medical technology has improved the management and monitoring of the condition. From the advent of CGM’s to the impact of GLP-1’s on the medical device industry, this track will discuss not only how technology is treating diabetes but the potential to reverse the root causes of the disease.

We’ll begin with a focus on technology that enables the measurement of disease. In our second session, we’ll discuss interventions that treat the progression of the disease including surgical solutions. During our last panel, we’ll discuss how medical technology can improve the ongoing maintenance of the disease, as well as proactively reduce complications.
Cezanne 1-2
Maternal Health Track
Within our Maternal Health Track, we’ll focus on current technology challenges and opportunities in pregnancy and post-natal care. Our speakers will discuss how advanced medical technologies can significantly impact the journey from conception through birth and beyond. By integrating innovation across the entire continuum, we can enhance the overall quality of care and improve health outcomes.

Our first session will focus on technology utilized prenatally including remote monitoring and diagnostics. We’ll continue the conversation with a discussion on interventional technology, specifically tech used in a hospital or delivery room setting, such as technology used perform safe emergent procedures. We’ll round out the day with our last session discussing technology to be utilized post-delivery, such as cardiac monitoring, infection prevention, and mental health solutions.
Musculoskeletal Health Track
Within our Musculoskeletal Health Track, we’ll dive into the latest advancements in medical technology that aim to measure, treat, and replace damaged or dysfunctional musculoskeletal components, facilitating improved mobility, stability, and overall function. From implants to mobility aids, wound care to wearables, join leaders in orthopedics as they discuss the evolution of technology and care models to support comprehensive patient care.

We’ll begin our Musculoskeletal Health Track with a conversation on diagnostic or analytical technologies. The second session will discuss musculoskeletal interventions including those relevant to sports medicine. Our final session will cover healing and rehabilitation technologies. From hospital to home, this session will examine medical technologies that are enabling patients to attain and maintain peak mobility.
Renior 1&2
4:00 PMSymposium Concludes

GALA Agenda

5:45 PMRegistration for the Gala OpensPicasso 1-6
6:00 PMCocktail ReceptionPicasso 1-6
7:15 PMDinner & ProgramPicasso 1-6
8:30 PMDessert ReceptionPicasso 1-6
10:30 PMGala Concludes